Free Trial

Upstream Bio (UPB) Insider Trading & Ownership

Upstream Bio logo
$16.21 -0.40 (-2.41%)
(As of 12/20/2024 05:16 PM ET)

Upstream Bio (NASDAQ:UPB) Insider Buying and Selling Activity

Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$34 M
Number Of
Insiders Selling
(Last 12 Months)
0
Get UPB Insider Trade Alerts

Want to know when executives and insiders are buying or selling Upstream Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

UPB Insider Buying and Selling by Quarter

Upstream Bio Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/15/2024Ai Upstream LlcMajor ShareholderBuy1,175,000$17.00$19,975,000.00  
10/15/2024Erez ChimovitsDirectorBuy825,000$17.00$14,025,000.00  
(Data available from 1/1/2013 forward)

UPB Insider Trading Activity - Frequently Asked Questions

The list of insiders at Upstream Bio includes Ai Upstream Llc, and Erez Chimovits. Learn more on insiders at UPB.

The following insiders have purchased UPB shares in the last 24 months: Ai Upstream Llc ($19,975,000.00), and Erez Chimovits ($14,025,000.00).

Insiders have purchased a total of 2,000,000 UPB shares in the last 24 months for a total of $34,000,000.00 bought.

Upstream Bio Key Executives

  • Mr. Aaron Deykin M.D. (Age 58)
    Chief Medical Officer & Head of Research and Development
    Compensation: $736.7k
  • Dr. E. Rand Sutherland M.D. (Age 54)
    M.P.H., MPH, CEO & Director
  • Mr. Michael Paul Gray CPA (Age 53)
    MBA, CFO & COO
  • Ms. Parika Petaipimol M.S.
    Head of Technical Operations
  • Ms. Lisa Fiering
    Senior Vice President of People & Culture
  • Mersedeh Miraliakbari Pharm.D.
    Senior Vice President of Regulatory Affairs & Quality
  • Ms. Fang Xie Ph.D.
    Vice President & Head of Biometrics
  • Dr. Sumathi Sivapalasingam M.D.
    VP & Head of Clinical Development
  • Ms. Maryse Courval M.S.
    VP & Head of Clinical Operations
  • William D. Collins
    Secretary


This page (NASDAQ:UPB) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners